![Mary Haak-Frendscho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Haak-Frendscho
Director/Board Member at
SURROZEN, INC.
Net worth: 75 333 $ as of 2026-09-29
Profile
Mary Haak-Frendscho was the founder of Compugen, Inc. (United States), founded in 2012, where the title held was Chairman from 2012 to 2016.
Current jobs include President, Chief Executive Officer & Director at Spotlight Therapeutics, Inc. since 2019; Director at Sirenas LLC since 2015; Director at Surrozen Operating, Inc. since 2021; and Independent Director at Surrozen, Inc. since 2021.
Former jobs include Chief Executive Officer & Director at Igenica Biotherapeutics, Inc. from 2012 to 2014; Chief Executive Officer & Director at Blueline Bioscience from 2016 to 2019; Director at Northern Biologics, Inc.; Principal at Genentech, Inc.; Principal at Abgenix, Inc.; Chief Scientific Officer, VP-Preclinical R&D at XOMA Royalty Corp.; President & Chief Scientific Officer at Takeda California, Inc. from 2008 to 2012; and Venture Partner at Versant Ventures Canada Ltd. from 2017 to 2019.
Education includes graduate degrees from the University of Washington and Stony Brook University, a doctorate from the University of Wisconsin, and an undergraduate degree from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SURROZEN INC 0.02% | 2026-05-12 | 2,341 ( 0.02% ) | 75 333 $ | 2026-09-29 |
Mary Haak-Frendscho active positions
| Companies | Position | Start |
|---|---|---|
| SURROZEN, INC. | Director/Board Member | 2021-02-28 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Director/Board Member | 2021-03-10 |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Develops gene editing therapeutics | Chief Executive Officer | 2018-12-31 |
Sirenas LLC
 Sirenas LLC Pharmaceuticals: MajorHealth Technology Develops proprietary drug discovery technology | Director/Board Member | 2015-09-30 |
Former positions of Mary Haak-Frendscho
| Companies | Position | End |
|---|---|---|
Blueline Bioscience
 Blueline Bioscience Investment ManagersFinance Acts as an alternative investment manager | Chief Executive Officer | 2018-12-31 |
Versant Ventures Canada Ltd.
 Versant Ventures Canada Ltd. Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 2018-12-31 |
Compugen, Inc. (United States) | Founder | 2015-12-31 |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Chief Executive Officer | 2013-12-31 |
Takeda California, Inc.
 Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | President | 2011-12-31 |
Education of Mary Haak-Frendscho
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
35
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Health Technology |
Sirenas LLC
Sirenas LLC Pharmaceuticals: MajorHealth Technology Develops proprietary drug discovery technology | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stony Brook University
 Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Compugen, Inc. (United States) | |
Takeda California, Inc.
Takeda California, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis | Health Services |
Blueline Bioscience
Blueline Bioscience Investment ManagersFinance Acts as an alternative investment manager | Finance |
Versant Ventures Canada Ltd.
Versant Ventures Canada Ltd. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Spotlight Therapeutics, Inc.
Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Develops gene editing therapeutics | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
- Stock Market
- Insiders
- Mary Haak-Frendscho
